Will Maier and Kelly Franchetti discuss orphan drugs and patients' role in clinical trials as demand in the market increases.
Read ArticleRare and orphan diseases insights
ICON's Rare and Orphan Diseases team provides analysis including whitepapers, blogs and contributions to media and industry conversations relating to all aspects of rare and orphan diseases in clinical trials.
Read more